Aqr Capital Management LLC Rubius Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.79 - $5.98 $129,687 - $981,682	164,161 New	164,161 $140,000
Q1 2022 May 16, 2022	SELL	$4.25 - $10.4 $73,146 - $178,994	-17,211 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$9.68 - $17.74 $101,591 - $186,181	-10,495 Reduced 37.88%	17,211 $167,000
Q3 2021 Nov 15, 2021	SELL	$17.6 - $25.91 $270,318 - $397,951	-15,359 Reduced 35.66%	27,706 $495,000
Q2 2021 Aug 16, 2021	BUY	$22.26 - $28.43 $958,626 - $1.22 Million	43,065 New	43,065 $1.05 Million

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.